| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers C > Headlines for Celldex Therapeutics Inc. > News item |
Bristol-Myers Squibb sells shares of Celldex, drops stake to 7.83%
By Lisa Kerner
Charlotte, N.C., Dec. 9 - Bristol-Myers Squibb Co. sold 414,276 shares of Celldex Therapeutics, Inc. between Nov. 30 and Dec. 8 priced from $4.48 to $4.71 each, according to a schedule 13D/A filed on Wednesday with the Securities and Exchange Commission.
On Nov. 23 and Nov. 24, Bristol-Myers Squibb, a New York biopharmaceutical company, sold 71,625 shares of Celldex, keeping a 9.14% interest, a prior SEC filing said.
Bristol-Myers Squibb reported beneficial ownership of 2,474,947 shares, or 7.83%, of Celldex, a Bloomsbury, N.J., biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.